Re: Apabetalone may reduce chemotherapy resistance in ovarian cancer

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10503 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Apabetalone may reduce chemotherapy resistance in ovarian cancer

in response to

Apabetalone may reduce chemotherapy resistance in ovarian cancer

imtesty

posted on Feb 28, 2021 09:38AM

It seems that apabetalone always comes to the rescue of other drugs to make them perform the way they should but much better. But as a stand-alone drug not so good. Is that about it???

Perhaps it can be for COVID-19.

"BETi, including the FDA breakthrough designated drug apabetalone, are promising candidates to prevent COVID-19 mediated cardiac damage."